Align Technology, Inc. (FRA:AFW)
Germany · Delayed Price · Currency is EUR | Market Cap | 9.80B +15.8% |
| Revenue (ttm) | 3.62B +4.4% |
| Net Income | 362.00M -5.5% |
| EPS | 5.13 -2.8% |
| Shares Out | n/a |
| PE Ratio | 26.71 |
| Forward PE | 13.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 136.95 |
| Previous Close | 131.80 |
| Day's Range | 136.95 - 137.05 |
| 52-Week Range | 111.65 - 166.60 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |
About Align Technology
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. T... [Read more]
Financial Performance
In 2025, Align Technology's revenue was $4.03 billion, an increase of 0.90% compared to the previous year's $4.00 billion. Earnings were $410.35 million, a decrease of -2.61%.
Financial numbers in USD Financial StatementsNews
Align Technology price target lowered to $200 from $220 at Mizuho
Mizuho lowered the firm’s price target on Align Technology (ALGN) to $200 from $220 and keeps an Outperform rating on the shares. The firm sees a “less optimistic” outlook for…
Align Technology price target lowered to $205 from $235 at Piper Sandler
Piper Sandler lowered the firm’s price target on Align Technology (ALGN) to $205 from $235 and keeps an Overweight rating on the shares. Clear aligner volumes measured across the firm’s…
Align Technology wins patent infringement case against Angelalign at UPC
Align Technology (ALGN) announces the decision of the Unified Patent Court, UPC, finding that aligner systems incorporating Angelalign’s (AGLFF) Torque Ridges feature infringe Align’s European Patent ...
Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court
SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System ...
Align Technology downgraded to Neutral from Outperform at Baird
Baird downgraded Align Technology (ALGN) to Neutral from Outperform with a price target of $162, down from $218.
Align Technology price target lowered to $215 from $235 at Leerink
Leerink lowered the firm’s price target on Align Technology (ALGN) to $215 from $235 and keeps an Outperform rating on the shares. The firm says there are very few expectations…
Align Technology price target lowered to $175 from $210 at Stifel
Stifel analyst Jonathan Block lowered the firm’s price target on Align Technology (ALGN) to $175 from $210 and keeps a Buy rating on the shares. U.S. Invisalign diligence is “weak”…
Align Technology downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Elizabeth Anderson downgraded Align Technology (ALGN) to In Line from Outperform with a price target of $155, down from $220. The firm cites a weakening consumer backdrop,…
Align Technology to Announce Third Quarter 2026 Results on October 28, 2026
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intr...
Align Technology Launches “SHIFT Happens” U.S. Campaign to Educate Adults About Lifelong Tooth Movement
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ int...
Align Technology Transcript: 2026 Global Healthcare Conference
U.S. and global orthodontics markets remain under-penetrated, with growth driven by new product launches, expanded financing, and targeted investments, especially in international markets. Guidance calls for mid-single digit case growth and margin expansion, while China presents both pricing pressure and new opportunities.
Align Technology to Speak at Upcoming Financial Conference
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, ...
Quentin Blackford to Join Align Technology Board of Directors
TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System ...
Align reports China judgement in its favor in patent infringement case
Align Technology (ALGN) announced that the Jinan Intermediate People’s Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology’s operating subs...
Align Technology Prevails in China Patent Infringement Action Against Angelalign
SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System ...
Align Technology Hosts 2026 Invisalign® Ortho Summit, Showcasing a “Beyond Possible” Vision for Connected Digital Orthodontics
LAS VEGAS & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners...
Align Technology to overhaul board following engagement with Elliott
Align Technology said on Wednesday it will add three new independent directors to its board and launch a review of its operations, following talks with activist investor Elliott Investment Managemen...
Align to appoint new independent directors, to repurchase $400M-$500M of shares
Align Technology (ALGN) announced several initiatives reflecting its commitment to strong corporate governance and shareholder value creation. Following discussions with Elliott Investment Management ...
Align Technology Announces Strategic Initiatives Consistent with Long-term Growth and Shareholder Value Creation Objectives
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, i...
Align Technology reports Q2 adjusted EPS $2.64, consensus $2.60
Reports Q2 revenue $1.056B, consensus $1.06B. Commenting on Align’s Q2’26 results, Align Technology (ALGN) President and CEO Joe Hogan said, “We delivered a solid second quarter with record revenues o...
Align Technology sees Q3 revenue $1B-$1.02B, consensus $1.02B
Sees Q3 adjusted gross margin roughly 71%. Sees Q3 adjusted operating margin roughly 24%.
Align Technology sees FY26 revenue growth 3%-4%
The company said, “Our full year 2026 revenue guidance continues to assume a benefit from foreign exchange that is consistent with the assumptions underlying our initial full year outlook. We…
Align Technology Announces Second Quarter 2026 Financial Results
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ int...
Align Technology Earnings Call Transcript: Q2 2026
Q2 2026 saw record revenues and clear aligner volumes, with strong international growth offsetting stable North America. Systems and services revenue declined due to a shift to lower-priced, flexible scanner models, but unit placements grew. Guidance calls for continued margin expansion and increased share repurchases.
Align Technology Earnings release: Q2 2026
Align Technology released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.